Why Should Pathologists Care about Participating in MIPS? by CAPcasts from the College of American Pathologists

In this CAPcast, we’ll speak with Diane Cardona, MD, FCAP, Chair of the Quality and Clinical Data Registry Affairs Committee, about why eligible pathologists should consider MIPS participation as a strategy to help protect revenues as well as a strategy to demonstrate their value instead of seeking a COVID exemption.